We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Northrim BanCorp
NRIM
$591M
| $311K | ﹤0.01% |
37,852
+11,296
| +43% | +$104K |
|
2527
PAR Technology
PAR
$706M
| $311K | ﹤0.01% |
14,297
+4,927
| +53% | +$95.2K |
|
2528
Mammoth Energy Services
TUSK
$142M
| $310K | ﹤0.01% |
17,229
+6,283
| +57% | +$154K |
|
|
HONE
2529
DELISTED
HarborOne Bancorp
HONE
| $309K | ﹤0.01% |
34,959
+11,389
| +48% | +$112K |
|
|
MRLN
2530
DELISTED
Marlin Business Services Corp
MRLN
| $309K | ﹤0.01% |
13,860
+3,865
| +39% | +$99.4K |
|
2531
Ares Capital
ARCC
$14.1B
| $308K | ﹤0.01% |
19,776
+45
| +0.2% | +$744 |
|
2532
Cytosorbents Corp
CTSO
$25M
| $308K | ﹤0.01% |
38,135
+13,505
| +55% | +$134K |
|
|
MRT
2533
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $308K | ﹤0.01% |
45,088
+11,318
| +34% | +$88.8K |
|
|
FNHC
2534
DELISTED
FedNat Holding Company Common Stock
FNHC
| $307K | ﹤0.01% |
15,412
+4,753
| +45% | +$104K |
|
2535
OrthoPediatrics
KIDS
$586M
| $306K | ﹤0.01% |
8,770
+3,129
| +55% | +$99.1K |
|
2536
Simulations Plus
SLP
$371M
| $305K | ﹤0.01% |
15,309
+5,000
| +49% | +$98.8K |
|
|
CETV
2537
DELISTED
Central European Media Enterprises Ltd
CETV
| $305K | ﹤0.01% |
109,709
+35,971
| +49% | +$118K |
|
|
CWBC
2538
Community West Bancshares
CWBC
$689M
| $304K | ﹤0.01% |
16,135
+5,017
| +45% | +$99.7K |
|
|
WOW
2539
DELISTED
WideOpenWest
WOW
| $304K | ﹤0.01% |
42,670
+12,373
| +41% | +$119K |
|
|
HABT
2540
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $304K | ﹤0.01% |
29,000
+8,846
| +44% | +$119K |
|
|
LTS
2541
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $304K | ﹤0.01% |
130,417
+42,333
| +48% | +$113K |
|
2542
Culp Inc
CULP
$44.8M
| $302K | ﹤0.01% |
15,989
+4,812
| +43% | +$104K |
|
|
SMMF
2543
DELISTED
Summit Financial Group, Inc.
SMMF
| $301K | ﹤0.01% |
15,603
+4,808
| +45% | +$101K |
|
|
SRGA
2544
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $301K | ﹤0.01% |
2,708
+825
| +44% | +$107K |
|
2545
Regional Management Corp
RM
$305M
| $300K | ﹤0.01% |
12,483
+3,814
| +44% | +$104K |
|
2546
Costamare
CMRE
$1.8B
| $299K | ﹤0.01% |
68,161
+20,383
| +43% | +$108K |
|
2547
Clarus
CLAR
$130M
| $298K | ﹤0.01% |
29,605
+9,365
| +46% | +$98K |
|
2548
Abeona Therapeutics
ABEO
$393M
| $297K | ﹤0.01% |
1,666
+532
| +47% | +$116K |
|
2549
Standard BioTools
LAB
$313M
| $297K | ﹤0.01% |
34,489
+10,358
| +43% | +$80.7K |
|
2550
Upwork
UPWK
$1.16B
| $297K | ﹤0.01% |
+16,424
| New | +$305K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.